Muscle atrophy in response to cytotoxic chemotherapy is dependent on intact glucocorticoid signaling in skeletal muscle

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Braun, Theodore P ^a   Szumowski, Marek ^a   Levasseur, Peter R ^a   Grossberg, Aaron J ^c   Zhu, Xinxia ^a   Agarwal, Anupriya ^a,b   Marks, Daniel L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PROVIDENCE ST VINCENT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; PROTEASOME; UBIQUITIN; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOLYSOSOME; CACHEXIA; CANCER CHEMOTHERAPY; CONTROLLED STUDY; GENE INDUCTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; MOUSE; MUSCLE ATROPHY; MUSCLE MASS; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; ANTIBODY SPECIFICITY; APOPTOSIS; AUTOPHAGY; BLOOD; CHEMICALLY INDUCED; DEFICIENCY; DRUG EFFECTS; FEMALE; GENE INACTIVATION; GENETICS; HEART MUSCLE; LYSOSOME; MALE; METABOLISM; NEOPLASMS; ORGAN SIZE; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CACHEXIA; CORTICOSTERONE; FEMALE; GENE KNOCKOUT TECHNIQUES; GLUCOCORTICOIDS; LYSOSOMES; MALE; MICE; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOCARDIUM; NEOPLASMS; ORGAN SIZE; ORGAN SPECIFICITY; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION; UBIQUITIN;

EID: 84907457093     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106489     Document Type: Article

References (38)

1. Tan BHL, Birdsell LA, Martin L, Baracos VE, Fearon KCH (2009) Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 15: 6973-6979.
2. DeWys WD (1986) Weight loss and nutritional abnormalities in cancer patients: incidence, severity and significance. Clinics In Oncology 5: 251-261.
3. Tisdale MJ (2002) Cachexia in cancer patients. Nat Rev Cancer 2: 862-871.
4. Braun TP, Grossberg AJ, Krasnow SM, Levasseur PR, Szumowski M, et al. (2013) Cancer-and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle. FASEB J 27: 3572-3582.
5. He WA, Berardi E, Cardillo VM, Acharyya S, Aulino P, et al. (2013) NF-kBmediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J Clin Invest 123: 4821-4835.
6. Cai D, Frantz JD, Tawa NE, Melendez PA, Oh B-C, et al. (2004) IKKbeta/NFkappaB activation causes severe muscle wasting in mice. Cell 119: 285-298.
7. Damrauer J, Stadler M, Acharyya S, Baldwin AS (2008) Chemotherapy-induced muscle wasting: association with NF-kB and cancer cachexia. Basic Appl Myol 18: 139-148.
8. Morley JE, Thomas DR, Wilson M-MG (2006) Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 83: 735-743.
9. Richey LM, George JR, Couch ME, Kanapkey BK, Yin X, et al. (2007) Defining cancer cachexia in head and neck squamous cell carcinoma. Clin Cancer Res 13: 6561-6567.
10. Dü lger H, Alici S, Sekerog?lu MR, Erkog R, Ozbek H, et al. (2004) Serum levels of leptin and proinflammatory cytokines in patients with gastrointestinal cancer. Int J Clin Pract 58: 545-549.
11. Acharyya S, Ladner KJ, Nelsen LL, Damrauer J, Reiser PJ, et al. (2004) Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 114: 370-378.
12. Braun TP, Zhu X, Szumowski M, Scott GD, Grossberg AJ, et al. (2011) Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis. J Exp Med 208: 2449-2463.
13. Schakman O, Dehoux M, Bouchuari S, Delaere S, Lause P, et al. (2012) Role of IGF-I and the TNFa/NF-kB pathway in the induction of muscle atrogenes by acute inflammation. Am J Physiol Endocrinol Metab 303: E729-E739.
14. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, et al. (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708.
15. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, et al. (2007) FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 6: 458-471.
16. Zhang S, Liu X, Bawa-Khalfe T, Lu L-S, Lyu YL, et al. (2012) Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med 18: 1639-1642.
17. Sauter KAD, Wood LJ, Wong J, Iordanov M, Magun BE (2011) Doxorubicin and daunorubicin induce processing and release of interleukin-1b through activation of the NLRP3 inflammasome. Cancer Biol Ther 11: 1008-1016.
18. Limberaki E (2011) Cortisol levels and serum antioxidant status following chemotherapy. Health 03: 512-517.
19. Morrow GR, Hickok JT, Andrews PLR, Stern RM (2002) Reduction in serum cortisol after platinum based chemotherapy for cancer: A role for the HPA axis in treatment-related nausea? Psychophysiology 39: 491-495.
20. Weymann KB, Wood LJ, Zhu X, Marks DL (2014) A role for orexin in cytotoxic chemotherapy-induced fatigue. Brain Behav Immun 37: 84-94.
21. Bethin KE, Vogt SK, Muglia LJ (2000) Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc Natl Acad Sci USA 97: 9317-9322.
22. Robert F, Mills JR, Agenor A, Wang D, DiMarco S, et al. (2012) Targeting protein synthesis in a Myc/mTOR-driven model of anorexia-cachexia syndrome delays its onset and prolongs survival. Cancer Res 72: 747-756.
23. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL (2001) Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 98: 14440-14445.
24. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, et al. (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412.
25. Shimizu N, Yoshikawa N, Ito N, Maruyama T, Suzuki Y, et al. (2011) Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. Cell Metab 13: 170-182.
26. Gilson H, Schakman O, Combaret L, Lause P, Grobet L, et al. (2007) Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy. Endocrinology 148: 452-460.
27. Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, et al. (2009) Autophagy is required to maintain muscle mass. Cell Metab 10: 507-515.
28. Doyle A, Zhang G, Abdel Fattah EA, Eissa NT, Li Y-P (2011) Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways. FASEB J 25: 99-110.
29. Bruchard M, Mignot G, Derangère V, Chalmin F, Chevriaux A, et al. (2013) Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth. Nat Med 19: 57-64.
30. Janelsins MC, Mustian KM, Palesh OG, Mohile SG, Peppone LJ, et al. (2012) Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support Care Cancer 20: 831-839.
31. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, et al. (2007) Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13: 1050-1059.
32. Mukaida N, Morita M, Ishikawa Y, Rice N, Okamoto S, et al. (1994) Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem 269: 13289-13295.
33. Dhabhar FS, McEwen BS (1999) Enhancing versus suppressive effects of stress hormones on skin immune function. Proc Natl Acad Sci USA 96: 1059-1064.
34. Tanaka H, Hirano F, Nomura Y, Miura T, Makino Y, et al. (1994) Relative glucocorticoid potency revisited. Rheumatol Int 14: 9-12.
35. Willis MS, Ike C, Li L, Wang D-Z, Glass DJ, et al. (2007) Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo. Circ Res 100: 456-459.
36. Usui S, Maejima Y, Pain J, Hong C, Cho J, et al. (2011) Endogenous muscle atrophy F-box mediates pressure overload-induced cardiac hypertrophy through regulation of nuclear factor-kappaB. Circ Res 109: 161-171.
37. Li H-H, Willis MS, Lockyer P, Miller N, McDonough H, et al. (2007) Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins. J Clin Invest 117: 3211-3223.
38. Kobayashi S, Volden P, Timm D, Mao K, Xu X, et al. (2010) Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death. J Biol Chem 285: 793-804.